✦ LIBER ✦

HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China

✍ Scribed by Wei, Zheng; Zou, Shanhua; Li, Feng; Cheng, Zhixiang; Li, Junmin; Wang, Jianmin; Wang, Chun; Chen, Fangyuan; Cao, Junning; Cheng, Yunfeng

Book ID: 121543728
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 437 KB
Volume: 31
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-014-0845-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retrospective analysis of primary gastri

Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan

✍ Tsutomu Tanaka; Kazuyuki Shimada; Kazuhito Yamamoto; Yoshiki Hirooka; Yasumasa N 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 149 KB

The derived neutrophil to lymphocyte rat

The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma

✍ Troppan, K; Deutsch, A; Gerger, A; Stojakovic, T; Beham-Schmid, C; Wenzl, K; Neu 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 324 KB

An enhanced International Prognostic Ind

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

✍ Zhou, Z.; Sehn, L. H.; Rademaker, A. W.; Gordon, L. I.; LaCasce, A. S.; Crosby-T 📂 Article 📅 2014 🏛 American Society of Hematology 🌐 English ⚖ 528 KB

Dose-adjusted EPOCH plus rituximab is an

Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study

✍ Julio García-Suárez; Helena Bañas; Ignacio Arribas; Dunia De Miguel; Teresa Pasc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

86 POSTER Aberrant promoter hypermethyla

86 POSTER Aberrant promoter hypermethylation of DAPK gene is an independent prognostic factor in patients with diffuse large B-cell lymphomas

✍ K. Amara; M. Trimeche; S. Ziadi; L. Laatiri; M. Hachana; S. Korbi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Low absolute lymphocyte count is a poor

Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients’ survival benefit from rituximab

✍ Yasuhiro Oki; Kazuhito Yamamoto; Harumi Kato; Yachiyo Kuwatsuka; Hirofumi Taji; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB